Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rskr
    Senior Member
    • Oct 2010
    • 249

    #46
    Originally posted by frozenlyse View Post
    Benchmarking alignment algorithms was an interesting and exciting field in 2008 - in 2011, not so much.
    Yep it was more important when you have 36mers to know how bad the alignments with them are. Now that we have 100mers, we can be a little more confident in our alignments.

    Comment

    • pmiguel
      Senior Member
      • Aug 2008
      • 2328

      #47
      Originally posted by rskr View Post
      Yep it was more important when you have 36mers to know how bad the alignments with them are. Now that we have 100mers, we can be a little more confident in our alignments.
      Well, don't be coy. What benchmarking protocol would satisfy you? Please be specific.

      --
      Phillip

      Comment

      • rskr
        Senior Member
        • Oct 2010
        • 249

        #48
        Originally posted by pmiguel View Post
        Well, don't be coy. What benchmarking protocol would satisfy you? Please be specific.

        --
        Phillip

        BWA, comes with a test suite, that will generate randomized reads, and evaluate them.

        Pretty easy, only reason not to do it is you know it isn't good.

        wgsim does do some error modeling and biological zygosity, but it doesn't do a very sophisticated job of the error modeling such as quality and error decreasing at the ends of reads, so it is still somewhat optimistic. Also the scoring is a little odd it doesn't measure the exact SNPs, and indels, but only if the reads were in the right place +-5bp, and if a read maps wrong multiple times that counts against the error multiple. That could be improved, but it will give a pretty good idea of what the accuracy really is.

        The best thing about bench marking? Its cheap!

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...